Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study
Clinical trial NCT00768859 · COMPLETED
Trial details
- NCT number
- NCT00768859
- Sponsor
- The Netherlands Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2011-08-01
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.